Long-term quality of life and acceptance of implantable cardioverter-defibrillator therapy: results of the European Heart Rhythm Association survey.

导出原文传递

翻译打印收藏纠错

作者： Łukasz,Januszkiewicz ^[1] ; Sérgio,Barra ^[2] ; Rui,Providencia ^[3] ; Giulio,Conte ^[4] ; Carlo,de Asmundis ^[5] ; Julian K R,Chun ^[6] ; Michał M,Farkowski ^[7] ; Jose M,Guerra ^[8] ; Eloi,Marijon ^[9] ; Serge,Boveda ^[10]

作者单位： 1st Department of Cardiology, Medical University of Warsaw, Poland. ^[1] Cardiology Department, Hospital da Luz Arrabida, V. N. Gaia, Portugal. ^[2] Barts Heart Centre, St. Bartholomew's Hospital, Barts Health NHS Trust, London, UK. ^[3] Institute of Health Informatics Research, University College of London, London, UK. ^[4] Cardiology Department, Fondazione CardiocentroTicino, Lugano, Switzerland. ^[5] Universita` della Svizzera Italiana Lugano, Lugano, Switzerland. ^[6] Heart Rhythm Management Centre, Universitair Ziekenhuis Brussel - Vrije Universiteit Brussel, Brussels, Belgium. ^[7] CCB, Cardiology, Med. Klinik III, Markuskrankenhaus, Frankfurt, Germany. ^[8] 2nd Department of Heart Arrhythmia, National Institute of Cardiology, Warsaw, Poland. ^[9] Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Universidad Autonoma de Barcelona, CIBERCV, Barcelona, Spain. ^[10] University of Paris, Paris, France. ^[11] Cardiology Department, European Georges Pompidou Hospital, Paris, France. ^[12] Paris Cardiovascular Research Center, INSERM Unit 970, Paris, France. ^[13] Heart Rhythm Department, Clinique Pasteur, 31076 Toulouse, France. ^[14]

关键词 Cardiac resynchronization therapy Complications EHRA survey Implantable cardioverter-defibrillator Patient attitude Patient education Patient fears Quality of life ‘Living with an ICD’ programme